ImmunoPrecise Antibodies Ltd.
IPA
$1.28
$0.021.59%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/22/2024
-
The Fly
4/12/2024
-
The Fly
4/12/2024
-
Accesswire
3/29/2024
-
Zolmax
3/28/2024
-
TipRanks Financial Blog
3/28/2024
-
Business Wire
3/28/2024
-
Benzinga
3/20/2024
-
Seeking Alpha - Healthcare
3/20/2024
-
Business Wire
3/19/2024
-
Zolmax
3/15/2024
-
Insider Monkey
3/15/2024
-
GuruFocus
3/14/2024
-
Seeking Alpha: Transcripts
3/14/2024
-
SeekingAlpha
3/14/2024
-
InvestorPlace
3/14/2024
-
Zacks Investment Research
3/14/2024
-
Business Wire
3/8/2024
-
Accesswire
3/7/2024
-
TipRanks Financial Blog
3/7/2024
-
Business Wire
3/4/2024
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 14, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Jul 8 and 12 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
250-483-0308
Address
3204–4464 Markham Street
Victoria, BC V8Z 7X8
Victoria, BC V8Z 7X8
Country
Year Founded
Business Description
Sector
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex...
more
